Our Myeloma Expertise
At The James, we have a team of physicians and physician-researchers who specialize in diagnosing and treating multiple myeloma. With research and treatment areas under one roof, we are better able to translate research advances to patient care – so our team of specialists can provide the best possible care for patients with multiple myeloma.
As one of only four institutions approved by the National Cancer Institute (NCI) to conduct phase I and II clinical trials on NCI sponsored anticancer agents, the OSUCCC – James has access to more leading-edge targeted cancer therapies than most hospitals across America. That translates to better outcomes, fewer side effects and more hope. Search open cancer clinical trials